Mezzion Pharma Co (XKRX:140410) Ending Cash Position : ₩35,635 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co Ending Cash Position?

Mezzion Pharma Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩35,635 Mil.

Mezzion Pharma Co's quarterly Ending Cash Position declined from Sep. 2023 (₩41,502 Mil) to Dec. 2023 (₩40,246 Mil) and declined from Dec. 2023 (₩40,246 Mil) to Mar. 2024 (₩35,635 Mil).

Mezzion Pharma Co's annual Ending Cash Position increased from Dec. 2021 (₩24,210 Mil) to Dec. 2022 (₩29,399 Mil) and increased from Dec. 2022 (₩29,399 Mil) to Dec. 2023 (₩40,246 Mil).

Mezzion Pharma Co Ending Cash Position Historical Data

The historical data trend for Mezzion Pharma Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co Ending Cash Position Chart

Mezzion Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

15,644.31

35,854.07

24,209.66

29,399.07

40,246.15

Mezzion Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															22,869.33	42,987.71	41,501.51	40,246.15	35,634.66

Mezzion Pharma Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mezzion Pharma Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	29399.068	+	10847.085
	=	40,246

Mezzion Pharma Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	40246.152	+	-4611.492
	=	35,635

Mezzion Pharma Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Mezzion Pharma Co (XKRX:140410) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879

Website

http://www.mezzion.co.kr

Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines